A Phase 1 Dose-escalation Study of a Cell Cycle Inhibitor With and Without Gemcitabine in Patients With Solid Tumors or Lymphoma (Study P05248AM5)

This study has been completed.

Study NCT00779584 Information provided by Schering-Plough

First Received: October 22, 2008 Last Updated: August 18, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	May 2011
Primary Completion Date:	November 2010 (Final data collection date for primary outcome measure)